RESPONSE TO CHALLENGE WITH GONADOTROPIN-RELEASING-HORMONE AGONIST IN A MOTHER AND HER 2 SONS WITH A CONSTITUTIVELY ACTIVATING MUTATION OF THE LUTEINIZING-HORMONE RECEPTOR - A CLINICAL RESEARCH-CENTER STUDY
Im. Rosenthal et al., RESPONSE TO CHALLENGE WITH GONADOTROPIN-RELEASING-HORMONE AGONIST IN A MOTHER AND HER 2 SONS WITH A CONSTITUTIVELY ACTIVATING MUTATION OF THE LUTEINIZING-HORMONE RECEPTOR - A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3802-3806
The pituitary-gonadal axis was evaluated in a mother after two of her
sons with familial mate-limited pseudoprecocious puberty were found to
have a constitutively activating mutation of the LH receptor (LHR). G
enotyping demonstrated that all showed a mutation in one of the two al
leles, a substitution of Gly for Asp(578) in the sixth transmembrane s
egment of the LHR. Ovarian function was normal in the 36-yr-old mother
as assessed by LH dynamics and FSH and androgen levels throughout the
menstrual cycle. Hormonal responses to acute GnRH agonist (nafarelin)
challenge, chronic GnRH agonist administration, and dexamethasone wer
e also normal. Studies of the boys upon presentation at 2.4 and 3.5 yr
of age revealed that acute LH responses to nafarelin were in the hypo
gonadotropic range, and the FSH responses were prepubertal despite the
presence of late pubertal testosterone blood levels. Upon the incepti
on of true puberty at 11 yr of age in the older brother, gonadotropin
responses normalized for the state of development. The data show that
this activating LHR mutation does not cause functional ovarian hyperan
drogenism and causes only incomplete pubertal activation of Leydig cel
ls. The results are compatible with relatively low constitutive activi
ty associated with this structural abnormality of LHR.